---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-026930"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T08:56:19.279690+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BIO-key Q2 2024 revenue down 42% YoY to $1.1M; net loss narrows to $1.7M

## Summary
- Q2 revenue $1.1M vs $1.9M YoY; delayed ~$450k software license fees and lower project services.
- Net loss improved to $1.7M ($1.00/share) from $2.6M ($4.71/share) in Q2 2023, helped by $1M prior-year hardware reserve.
- Gross margin surged to 77.0% from 16.7% on absence of hardware reserve and higher services margins.
- Cash used in operations in H1 2024 fell 48% to $1.1M vs $2.1M in H1 2023.
- Recent wins: Williamsburg VA, LA LGBT Center, University of Iowa Hospital; launched Passkey:YOU product.

## SEC filing metadata
- accession: 0001437749-24-026930
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774924026930/0001437749-24-026930-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774924026930/bkyi20240814_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-026930
- JSON: https://secwatch.observer/filing/0001437749-24-026930.json
- Plain text: https://secwatch.observer/filing/0001437749-24-026930.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.